Carnegie acted as sole co-lead manager in the secondary placing of 25 million shares in Chr. Hansen Holding at a subscription price at DKK 118 per share. Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments.January, 2011.